Camden Capital, LLC Moderna, Inc. Transaction History

Camden Capital, LLC

  • $887 Million
  • Q4 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 11, 2020
SELL
$29.67 - $80.0 $402,028 - $1.08 Million
-13,550 Closed
0 $0
Q1 2020

Apr 13, 2020
BUY
$17.78 - $31.58 $9,779 - $17,369
550 Added 4.23%
13,550 $413,000
Q4 2019

Feb 10, 2020
BUY
$13.93 - $21.28 $181,090 - $276,640
13,000 New
13,000 $254,000

Others Institutions Holding MRNA

# of Institutions
919
Shares Held
255M
Call Options Held
19M
Put Options Held
24.2M
View Full List

About Moderna, Inc.

MRNA Quotes by TradingView
  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Camden Capital, LLC Portfolio

Follow Camden Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Camden Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Camden Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email